CBAV Share Price Performance
€59.40
17.30 (41.09%)
34.5% undervalued intrinsic discount
€90.72
Fair Value
Price €59.40
Imthetxarbi €90.72
Khalid06 €69.00
Fair Value€90.72
Share Pricen/a
Clínica Baviera, S.A. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 33 Fair Values set on narratives written by author
CBAV Community Narratives
IM
Fair Value
·Fair Value €90.72 34.5% undervalued intrinsic discount
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
KH
Fair Value
·Fair Value €69 13.9% undervalued intrinsic discount
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
2users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Baviera: Europe's Most Capital-Efficient Eye Care Compounder — Trading at Distressed Multiples While Delivering 15% CAGR and 40% ROCE. Fair Value €88/share ### The Business Clínica Baviera is Europe's leading specialist ophthalmology clinic network, focused on laser vision correction and intraocular surgery.Read more
IM
€90.72
34.5% undervalued intrinsic discount
Fair Value
Revenue
15.4% p.a.
Profit Margin
17%
Future PE
18x
Price in 2031
€129.17
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
A steady eye-care business throws off a lot of cash, yet the market may be overlooking it. The big question is whether paying out so much to shareholders slows its growth less than people fear.Read more
KH
€69
13.9% undervalued intrinsic discount
Fair Value
Revenue
13.2% p.a.
Profit Margin
14.68%
Future PE
13.54x
Price in 2034
€131.93
Trending Discussion
Recently Updated Narratives
IM
Baviera: A 40% ROCE Compounding Machine Trading at Distressed Multiples — Fair Value €88/share
Fair Value: €90.72 34.5% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
KH
The Undervaluation of Clinica Baviera: An Opportunity for Investors?
Fair Value: €69 13.9% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Proven track record with adequate balance sheet and pays a dividend.
1 Risk
2 Rewards
Clínica Baviera, S.A. Key Details
About CBAV
- Founded
- 1992
- Employees
- 1592
- CEO
- WebsiteView website
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is headquartered in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.
